Efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double‐blind, phase 3 trial

AIM: To assess the efficacy and safety of once‐daily ipragliflozin 50 mg versus placebo in Japanese people with type 1 diabetes mellitus (T1DM) inadequately controlled with insulin. MATERIALS AND METHODS: We conducted a multicentre, double‐blind, parallel‐group, placebo‐controlled phase 3 study. Par...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaku, Kohei, Isaka, Hiroyuki, Sakatani, Taishi, Toyoshima, Junko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772182/
https://www.ncbi.nlm.nih.gov/pubmed/31173455
http://dx.doi.org/10.1111/dom.13807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772182/
https://www.ncbi.nlm.nih.gov/pubmed/31173455
http://dx.doi.org/10.1111/dom.13807

Ejemplares similares